Local and Global News
OncoQuest Inc, a subsidiary of Edmonton-based Quest PharmaTech Inc., announce positive results from its pre-clinical pharmacology studies using its Anti-MUC1 antibody, MAb AR20.5, against pancreatic cancer in a mouse model.
Wednesday, October 5, 2016
Singularity University (SU) is offering a spot in their coveted accelerator program to innovative companies in the life sciences.
Thursday, September 29, 2016
Ceapro announce the grand opening of its new 30,000-square-foot bioprocessing extraction / manufacturing facility in Edmonton.
BioAlberta recognized leaders within Alberta’s life sciences industry for their innovation and achievements and for inspiring new ways of thinking!
Quest PharmaTech Announces Filing of Restated Audited Financial Statements for the Year Ended January 31, 2016 and for the Quarter Ended April 30, 2016
Wednesday, August 10, 2016
Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), today announces the filing on SEDAR of restated financial statements for the year ended January 31, 2016 and for the three-month period ended April 30, 2016 and restated management discussion.